⌕
PTC Therapeutics · PTCT · Nasdaq
Tenet 57 · Mixed
Compare
$60.97−3.97%At closeTenet 57 · Mixed
$60.97−2.52 (−3.97%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

PTC Therapeutics (PTCT) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 385 filers, Jun 30, 2026
# 13F FUNDS
385
13F VALUE
$8.3B
101.4M shares
Withheld: the 13F filers report more shares than the company has outstanding, which happens when shared or lent shares are counted twice. The filer count, shares and value are as filed.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 14, 2026SCHMERTZLER MICHAELdirectorDisposed · Open-market sale2,118$59.52↗
Oct 14, 2026SCHMERTZLER MICHAELdirectorDisposed · Open-market sale382$60.14↗
Oct 9, 2026Boulding Mark ElliottEXEC. VP AND CLOAcquired · Option exercise192$39.42↗
Oct 9, 2026Boulding Mark ElliottEXEC. VP AND CLODisposed · Open-market sale192$64.26↗
Oct 9, 2026Boulding Mark ElliottEXEC. VP AND CLODisposed · Option exercise192Stock Option (Right to Buy)—↗
Oct 7, 2026SCHMERTZLER MICHAELdirectorDisposed · Open-market sale2,447$63.38↗
Oct 7, 2026SCHMERTZLER MICHAELdirectorDisposed · Open-market sale53$63.95↗
Oct 6, 2026Boulding Mark ElliottEXEC. VP AND CLOAcquired · Option exercise435$39.42↗
Oct 6, 2026Boulding Mark ElliottEXEC. VP AND CLODisposed · Open-market sale435$64.16↗
Oct 6, 2026Boulding Mark ElliottEXEC. VP AND CLODisposed · Option exercise435Stock Option (Right to Buy)—↗
Oct 5, 2026Boulding Mark ElliottEXEC. VP AND CLOAcquired · Option exercise1,638$39.42↗
Oct 5, 2026Boulding Mark ElliottEXEC. VP AND CLODisposed · Open-market sale1,638$64.03↗
Oct 5, 2026Boulding Mark ElliottEXEC. VP AND CLODisposed · Option exercise1,638Stock Option (Right to Buy)—↗
Sep 30, 2026STEELE GLENN JR MD PHDdirectorAcquired · Option exercise12,000$11.23↗
Sep 30, 2026STEELE GLENN JR MD PHDdirectorDisposed · Open-market sale12,000$65.16↗
Sep 30, 2026STEELE GLENN JR MD PHDdirectorDisposed · Option exercise12,000Stock Option (Right to Buy)—↗
Sep 17, 2026SCHMERTZLER MICHAELdirectorDisposed · Open-market sale9,624$67.83↗
Sep 17, 2026SCHMERTZLER MICHAELdirectorDisposed · Open-market sale376$68.45↗
Sep 16, 2026SCHMERTZLER MICHAELdirectorDisposed · Open-market sale2,994$66.58↗
Sep 16, 2026SCHMERTZLER MICHAELdirectorDisposed · Open-market sale7,006$67.35↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold PTC Therapeutics?

PTC Therapeutics was held by 385 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.